Cover Image

經導管主動脈瓣置換術 (TAVR) 的全球市場 (2016∼2020年)

Global Transcatheter Aortic Valve Replacement Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 350527
出版日期 內容資訊 英文 49 Pages
Back to Top
經導管主動脈瓣置換術 (TAVR) 的全球市場 (2016∼2020年) Global Transcatheter Aortic Valve Replacement Market 2016-2020
出版日期: 2016年01月20日 內容資訊: 英文 49 Pages

所謂經導管主動脈瓣置換術 (TAVR) 用設備,是可不除去損傷的主動脈瓣而修復的心血管設備,用於主動脈瓣逆流和主動脈瓣狹窄症,主動脈瓣變性等主動脈瓣疾病的治療。TAVR的治療方法,有經大腿方法 (經由大腿動脈) 和經心尖方法 (胸部的小切口) 2種。全球TAVR市場預計2016∼2020年以16.9%的年複合成長率(CAGR) 成長。

本報告提供全球經導管主動脈瓣置換術 (以下TAVR) 市場相關分析、市場概要和結構、市場規模趨勢 (今後5年的預測值)、各產品/各地區的詳細趨勢、推動&阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品與服務

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第6章 TAVR相關臨床實驗分析

第7章 成本分析

  • 經導管主動脈瓣置換治療的成本分析

第8章 各產品的市場區隔

  • 經大腿埋入方法
  • 經心尖埋入方法

第9章 地區區分

  • 全球TAVR市場:各地區的詳細趨勢 (今後6年份)
  • 歐洲、中東、非洲各國 (EMEA) 市場
  • 南北美洲市場
  • 亞太地區市場

第10章 美國的TAVR市場

第11章 推動市場要素

  • 隨著老年人口的增加,主動脈瓣狹窄症的患病人數增加
  • 在美國、日本的新經導管瓣膜埋入法的登場
  • 微創 (MI) 治療的普及

第12章 推動因素的影響力

第13章 市場課題

  • 併發症的潛在風險
  • 外科手術式的瓣埋入治療的競爭、威脅
  • 嚴格的法規
  • 熟練的專門醫生的不足

第14章 推動因素、課題的影響力

第15章 市場趨勢

  • 臨床實驗的興趣
  • TAVR技術及自我擴張式支架框架的開發
  • 年輕人、低風險患者設備

第16章 供應商環境

  • 競爭方案
  • 主要供應商分析
  • 其他卓越供應商

第17章 附錄

  • 簡稱集

第18章 關於Technavio


Product Code: IRTNTR8085

About Transcatheter Aortic Valve Replacement

Transcatheter heart valve replacement systems are cardiovascular devices that repair the aortic valve without removing the old and damaged valves. It is used to treat aortic valve disorders such as regurgitation, aortic stenosis, and degeneration. TAVI is performed in two ways, transfemoral approach (through the femoral artery) and transapical approach (through a small chest incision).

Technavio's analysts forecast the global TAVR market to grow at a CAGR of 16.9% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global TAVR market for the period 2015-2020. To calculate the market size, the report considers the revenue generated from the sales of transcatheter aortic valve implants.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Transcatheter Aortic Valve Replacement Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Edwards Lifesciences
  • Medtronic
  • Boston Scientific
  • St. Jude Medical

Other Prominent Vendors

  • Direct Flow Medical
  • JenaValve Technology
  • Meril Life Sciences
  • Sorin

Market driver

  • Rise in prevalence of aortic stenosis with increase in aging population
  • For a full, detailed list, view our report

Market challenge

  • Risk of potential complications
  • For a full, detailed list, view our report

Market trend

  • Focus on clinical trials
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Clinical trial studies on TAVR

PART 07: Cost analysis

  • Cost analysis of aortic valve replacement procedures

PART 08: Market segmentation by product

  • Transfemoral implantation
  • Transapical implantation

PART 09: Geographical segmentation

  • Global TAVR market by geography 2015-2020
  • TAVR market in EMEA
  • TAVR market in Americas
  • TAVR market in APAC

PART 10: TAVR market in US

  • TAVR market in the US

PART 11: Market drivers

  • Rise in prevalence of aortic stenosis with increase in aging population
  • Launch of novel transcatheter valve implants in US and Japan
  • Increase in adoption of MI procedures

PART 12: Impact of drivers

PART 13: Market challenges

  • Risk of potential complications
  • Threat from surgical valve implant procedures
  • Stringent regulations
  • Lack of of skilled practitioners

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Focus on clinical trials
  • Development of TAVR technology and self-expandable stent frame
  • Devices for a younger and lower-risk patient population

PART 16: Vendor landscape

  • Competitive scenario
  • Key vendor analysis
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviation

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global TAVR market 2015-2020 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Snapshot of TAVR device studies in clinical trials
  • Exhibit 05: Comparison of the cost involved in valve replacement procedures (high risk group)
  • Exhibit 06: Segmentation of TAVR market by product
  • Exhibit 07: Comparison of transfemoral and transapical implantation approaches
  • Exhibit 08: Global TAVR market by geography 2015
  • Exhibit 09: Global TAVR market by geography 2020
  • Exhibit 10: Segmentation global TAVR market by geography 2015-2020
  • Exhibit 11: TAVR market in EMEA 2015-2020 ($ millions)
  • Exhibit 12: TAVR market in Americas 2015-2020 ($ millions)
  • Exhibit 13: TAVR market in APAC 2015-2020 ($ millions)
  • Exhibit 14: TAVR market in US 2015-2020 ($ millions)
  • Exhibit 15: Pipeline snapshot of TAVR in US
  • Exhibit 16: Impact of drivers
  • Exhibit 17: Impact of drivers and challenges
  • Exhibit 18: TAVR systems with FDA approval 2011-2015
  • Exhibit 19: TAVR systems with CE mark approval 2007-2015
  • Exhibit 20: Product portfolio matrix for key vendors 2015
  • Exhibit 21: Market share analysis 2015
  • Exhibit 22: Edwards Lifesciences: Key takeaways
  • Exhibit 23: Medtronic: Key takeaways
  • Exhibit 24: Boston Scientific: Key takeaways
  • Exhibit 25: St. Jude Medical: Key takeaways
Back to Top